VCM
RPC

Virtue Capital Management’s RADIENT PHARMACEUTICALS CORPORATIONS COMMON STOCK RPC Stock Holding History

Virtue Capital Management’s Portfolio RPC Stock Details RPC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-450,036
Closed – – 696
2017
Q4 		$0 Buy
+450,036
New – ﹤0.01% 537

Virtue Capital Management's RPC Position: Q1 2018 in Review

Virtue Capital Management sold out of RADIENT PHARMACEUTICALS CORPORATIONS COMMON STOCK (RPC) in Q1 2018, closing a stake of 450,036 shares.

Virtue Capital Management first reported a position in RPC in Q4 2017 and held it in 1 quarter. The position peaked at $0 in Q4 2017. 0 funds tracked by Wall St. Rank hold RPC as of Q1 2018.

  • Virtue Capital Management reported no remaining RADIENT PHARMACEUTICALS CORPORATIONS COMMON STOCK position as of Q1 2018 after selling out during the quarter.
  • Virtue Capital Management sold 450,036 RADIENT PHARMACEUTICALS CORPORATIONS COMMON STOCK shares in Q1 2018.
  • Virtue Capital Management first reported a position in RADIENT PHARMACEUTICALS CORPORATIONS COMMON STOCK in Q4 2017 and held it in 1 quarter.
  • Virtue Capital Management's RADIENT PHARMACEUTICALS CORPORATIONS COMMON STOCK position peaked at $0 in Q4 2017.
  • 0 funds tracked by Wall St. Rank held RADIENT PHARMACEUTICALS CORPORATIONS COMMON STOCK as of Q1 2018.

Based on Virtue Capital Management's 13F filing for Q1 2018, filed 15 May 2018.